Novo Nordisk to invest €2.1 billion in French obesity drug plant
Spread the love




Danish pharmaceutical giant Novo Nordisk will announce Thursday a major investment in a French production site to expand capacity for a blockbuster anti-obesity drug, the French presidency said.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *